info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Doxorubicin Companies

Doxorubicin is a chemotherapy medication used in the treatment of various cancers, including breast cancer, bladder cancer, lung cancer, leukemia, lymphoma, and others. It belongs to the class of medications called anthracyclines and works by interfering with the growth and spread of cancer cells in the body. Several pharmaceutical companies globally produce and distribute doxorubicin under various brand names.

Doxorubicin Key Companies

 

Latest Doxorubicin Companies Update


Jan 2024


Sun Pharmaceutical Industries Launched their Doxil® liposomal doxorubicin injection in the US market, entering the competition for this segment with a strong market share in other regions.Collaborated with research institutions to explore new applications of doxorubicin in combination therapies for treating other cancer types.


Baxter International Received FDA approval for their Doxorubicin HCl liposome injection, another player in the liposomal doxorubicin market offering healthcare providers additional options.Partnered with logistics companies to improve the distribution and availability of doxorubicin and other essential cancer drugs in underserved regions.


Venus Remedies Secured marketing authorization for doxorubicin among other chemotherapy drugs in the Philippines, expanding their reach in the Southeast Asian market.Invested in manufacturing upgrades and quality control measures to ensure consistent supply and high-quality doxorubicin production.


Padagis Pharmaceuticals Partnered with Ayana Pharma Ltd. to launch their AB-rated generic doxorubicin liposome injection in the US, increasing competition and potentially lowering costs for patients.Continued research efforts to develop next-generation drug delivery systems for doxorubicin with improved targeting and efficacy.


List of Doxorubicin Key Companies in The Market



  • Pfizer Inc

  • Sun Pharmaceutical Industries Ltd.

  • Janssen Pharmaceuticals

  • Accord Healthcare

  • Novartis AG

  • Sandoz

  • Reddy’s Laboratories Ltd.

  • Teva Pharmaceuticals

  • GLENMARK PHARMACEUTICALS LTD


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.